Scarica l'app Stockscreener
6.93
4.55%
-0.33
Precedente Chiudi:
$7.26
Aprire:
$7.445
Volume 24 ore:
39,866
Relative Volume:
0.32
Capitalizzazione di mercato:
$26.63M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.14%
1M Prestazione:
-34.81%
6M Prestazione:
-17.74%
1 anno Prestazione:
+268.62%
Intervallo 1D:
$6.91
$7.4611
Intervallo di 1 settimana:
$6.855
$7.65
Portata 52W:
$1.445
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Nome
Quantum Biopharma Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta QNTM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
6.93 | 27.90M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Quantum Biopharma Ltd Borsa (QNTM) Ultime notizie
QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in - The National Law Review
Quantum BioPharma closes private placement, enhances governance - MSN
QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in a Securities Fraud LawsuitContact Kaplan Fox & Kilsheimer LLP - NewMediaWire
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares - The Ithaca Journal
Quantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The Surge - MSN
Deadline to Lead in Securities Class Action Against Quantum Biopharma Ltd. (QNTM) is February 23, 2026Contact Kaplan Fox - FinancialContent
How supply chain issues affect Quantum BioPharma Ltd. stockJuly 2025 Big Picture & AI Forecasted Stock Moves - ulpravda.ru
Will Quantum BioPharma Ltd. stock attract ESG investorsJuly 2025 Momentum & Stepwise Trade Signal Guides - ulpravda.ru
How strong is Quantum BioPharma Ltd. stock balance sheetTreasury Yields & Real-Time Volume Trigger Notifications - ulpravda.ru
Will Quantum BioPharma Ltd. (0K91) stock enhance shareholder value2025 Price Momentum & Free Expert Verified Stock Movement Alerts - ulpravda.ru
QNTM CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026 - NewMediaWire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Why Quantum BioPharma Ltd. (0K91) stock signals breakout potentialTreasury Yields & Consistent Growth Stock Picks - ulpravda.ru
How Quantum BioPharma Ltd. stock reacts to global recession fearsRetail Trading Trends & Budget Friendly Trading Ideas - ulpravda.ru
Is Quantum BioPharma Ltd. (0K91) stock dividend growth reliableStock Watchlist Updates & Big Returns Small Capital - ulpravda.ru
QNTM DEADLINE: Investors of Quantum Biopharma Ltd. (QNTM) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 23, 2026 - NewMediaWire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Kaplan Fox Alerts Quantum Biopharma Ltd. (QNTM) Investors to a Se - The National Law Review
Kaplan Fox Alerts Quantum Biopharma Ltd. (QNTM) Investors to a Securities Class Action LawsuitDeadline is February 23, 2026 - FinancialContent
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QUANTUM BIOPHARMA Investors are Encouraged to Contact Kaplan Fox Regarding the Securities Class Action Lawsuit - NewMediaWire
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma - GlobeNewswire
Kaplan Fox Reminds Quantum Biopharma Ltd. (QNTM) Investors of a Securities Class Action Lawsuit - The Globe and Mail
Kaplan Fox Encourages Investors of Quantum Biopharma Ltd. (QNTM) to Contact the Firm Regarding the Securities Class Action Lawsuit - NewMediaWire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Kaplan Fox Alerts Investors of Quantum Biopharma Ltd. (QNTM) to a Securities Class Action Lawsuit - The National Law Review
QNTM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Contact UsConcord Monitor - FinancialContent
Kaplan Fox Alerts Investors to Securities Class Action on Behalf of Quantum Biopharma Ltd. (QNTM) Shareholders - NewMediaWire
Cannabis Stocks To Follow TodayDecember 11th - MarketBeat
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Celly Nutrition targets IPO with $10 million capital raise - MSN
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Quantum BioPharma Ltd Stock Analysis and ForecastVolatility Adjusted Trading & Small Budget Capital Gains - earlytimes.in
Quantum BioPharma completes key toxicity studies for Lucid-MS, paving way for Phase 2 MS trial - Indian Pharma Post
Cannabis Stocks To Follow NowDecember 1st - MarketBeat
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm - The Malaysian Reserve
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Quantum BioPharma completes oral dosing in key MS drug studies By Investing.com - Investing.com Australia
Quantum BioPharma completes 180-day toxicity dosing for lead MS drug Lucid-MS - MSN
Quantum Biopharma Ltd Azioni (QNTM) Dati Finanziari
Non sono disponibili dati finanziari per Quantum Biopharma Ltd (QNTM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):